Medical aestheticians offering injectable peptides should be well-trained and may consider advanced medical aesthetics courses to ensure they administer these treatments safely and within regulatory guidelines
Though human studies are less prevalent, preliminary findings indicate promising results
The newest GLP-1 drug, tirzepatide, was first approved in 2022 as Mounjaro for treatment of diabetes and later approved in 2024 as Zepbound for obesity
33 Isabel Tristn analyzed 80 serum and urine samples from COVID-19 patients (34 in intensive care and 46 hospitalized) and 32 healthy controls, identifying various metabolites, including TMAO, that could serve as biomarkers for the diagnosis, prognosis and severity assessment of COVID-19
Patients receive ongoing monitoring to keep treatment safe and effective
If you have been using an Ozempic pen that may have been stored incorrectly and notice that your blood glucose levels are higher than usual or less well controlled, this could indicate reduced medication potency